Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinic
| Image |  |
|---|---|
| Description | scientific article published on 31 May 2020 |
| Author/s |
author: Maximilian F Konig Jinoos Yazdany Milena A. Gianfrancesco Philip Robinson |
| Publication date | May 31, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |